EcoDrugPlus

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSEEUG00000015690
Gene Symbol: CHRNB4
1 External references
199 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSEEUG00000012688
Gene Symbol: F2
1 External references
86 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSEEUG00000004381
Gene Symbol: F3
1 External references
246 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSEEUG00000008734
Gene Symbol: F11
1 External references
215 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSEEUG00000015974
Gene Symbol: F12
1 External references
187 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSEEUG00000012252
Gene Symbol: CCDC6
1 External references
223 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSEEUG00000012572
Gene Symbol: CSF1R
1 External references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSEEUG00000005379
Gene Symbol: C1S
1 External references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSEEUG00000002909
Gene Symbol: C5
1 External references
212 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSEEUG00000003104
Gene Symbol: CRHR1
1 External references
208 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSEEUG00000007834
Gene Symbol: CDK1
1 External references
245 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSEEUG00000014081
Gene Symbol: CDK2
1 External references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).